Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Braz. j. microbiol ; 43(4): 1641-1645, Oct.-Dec. 2012. tab
Article in English | LILACS | ID: lil-665852

ABSTRACT

The role of rhinovirus asymptomatic infections in the transmission among close contacts subjects is unknown. We tested health care workers, a pair of one child and a family member and immunocompromised patients (n =191). HRV were detected on 22.9% symptomatic and 3.6% asymptomatic cases suggesting lower transmission among contacts.


Subject(s)
Humans , Child , Adult , Common Cold , Genetics, Microbial , In Vitro Techniques , Picornaviridae Infections , Rhinovirus , Polymerase Chain Reaction/methods , Methods , Patients , Prevalence
2.
Braz. j. microbiol ; 43(2): 739-743, Apr.-June 2012. tab
Article in English | LILACS | ID: lil-644491

ABSTRACT

Human rhinoviruses (HRVs) are the major cause of the common cold. HRVs were recently reclassified into the Enterovirus genus (HEV) in the Picornaviridae family. HRVs and other members of the HEV genus share many common features, including sense RNA genomes and partial nucleotide sequence identity. The aim of this study was to evaluate different HRV detection strategies. Samples from adults with acute respiratory infection (n = 291) who were treated in Sao Paulo Hospital (2001-2003) were tested using three assays. The first assay detected picornaviruses by RT-PCR and hybridization, the second detected rhinoviruses using RT-PCR/sequencing, and the third differentiated HRV from HEV using duplex semi-nested-RT-PCR. Analysis of the results obtained from the first two strategies revealed 83% concordance. Discordant samples were then evaluated by the third protocol, and 82% were negative. The picornavirus detection protocol was more sensitive but less specific than the rhinovirus detection protocols. The semi-nested protocol utilized in the present study was less sensitive and was not useful in differentiating HRV from HEV. Sequencing assays examining different genes would address the best strategy of confirming rhinovirus and enterovirus infections.


Subject(s)
Humans , Base Sequence , Common Cold , Genome, Viral , Hybridization, Genetic , In Vitro Techniques , Respiratory Tract Infections/genetics , Picornaviridae Infections/genetics , Picornaviridae/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Polymerase Chain Reaction/methods , Rhinovirus/genetics , Diagnosis , Methods , Patients
3.
Braz. j. infect. dis ; 10(4): 269-273, Aug. 2006. tab, graf
Article in English | LILACS | ID: lil-440681

ABSTRACT

Influenza vaccination of elderly people is efficacious and cost effective for the prevention of influenza and its complications. Some studies have pointed out low immunogenicity in this group. Health status has been poorly investigated as a risk factor that may influence the immune response to influenza vaccine. We established an immunization response study of a highly-matched elderly population in a nursing home. One-hundred-twenty subjects of Ashkenazian origin had their vaccine-induced antibody response assessed. Good response was obtained in 30.8 percent (37/120), and 31.7 percent (38/120) did not react. A lack of good response was found to be associated with dementia (P=0.016) in a multivariate analysis. In addition to dementia, malnutrition was frequently observed among poor responders, suggesting that these factors should be considered in vaccination studies. Chemoprophylaxis in addition to vaccination for elderly presenting dementia should be considered, particularly for those people living nursing homes.


Subject(s)
Aged , Aged, 80 and over , Female , Humans , Male , Influenza A virus/immunology , Influenza B virus/immunology , Influenza Vaccines/immunology , Influenza, Human/prevention & control , Antibodies, Viral/blood , Enzyme Multiplied Immunoassay Technique , Hemagglutination Inhibition Tests , Influenza, Human/immunology , Risk Factors
4.
Braz. j. med. biol. res ; 39(4): 519-523, Apr. 2006. ilus, tab
Article in English | LILACS | ID: lil-425090

ABSTRACT

Epidemiological data regarding tetanus and diphtheria immunity in elderly people in Brazil are scarce. During the First National Immunization Campaign for the Elderly in Brazil in April 1999, 98 individuals (median age: 84 years) received one tetanus-dyphtheria (Td) vaccine dose (Butantan Institute, lot number 9808079/G). Inclusion criteria were elderly individuals without a history of severe immunosuppressive disease, acute infectious disease or use of immunomodulators. Blood samples were collected immediately before the vaccine and 30 days later. Serum was separated and stored at -20°C until analysis. Tetanus and diphtheria antibodies were measured by the double-antigen ELISA test. Tetanus and diphtheria antibody concentrations lower than 0.01 IU/mL were considered to indicate the absence of protection, between 0.01 and 0.09 IU/mL were considered to indicate basic immunity, and values of 0.1 IU/mL or higher were considered to indicate full protection. Before vaccination, 18 percent of the individuals were susceptible to diphtheria and 94 percent were susceptible to tetanus. After one Td dose, 78 percent became fully immune to diphtheria, 13 percent attained basic immunity, and 9 percent were still susceptible to the disease. In contrast, 79 percent remained susceptible to tetanus, 4 percent had basic immunity and 17 percent were fully immune. Although one Td dose increases immunity to diphtheria in many elderly people who live in Brazil, a complete vaccination series appears to be necessary for the prevention of tetanus.


Subject(s)
Aged , Aged, 80 and over , Female , Humans , Male , Antibodies, Bacterial/blood , Diphtheria-Tetanus Vaccine/immunology , Diphtheria/prevention & control , Tetanus/prevention & control , Antibodies, Bacterial/immunology , Brazil , Diphtheria/immunology , Enzyme-Linked Immunosorbent Assay , Tetanus/immunology
5.
Braz. j. med. biol. res ; 29(4): 485-7, Apr. 1996. tab
Article in English | LILACS | ID: lil-163890

ABSTRACT

We developed and evaluated a specific test for herpes simplex virus (HSV) infection based on the secretion of HSV-specific antibodies by lymphocytes stimulated in vitro with HSV-1 antigens. The in vitro induced antibody production (IVIAP) test was used for the diagnosis of HSV infection in 43 seropositive selected subjects: 9 healthy subjects (controls), 30 symptomatic patients (26 of them immunocompromised and 4 immunocompetent) and 4 patients with varicella zoster infection. Anti-HSV antibodies were detected by an immune assay using an anti-human IgG peroxidase conjugate. The test showed a sensitivity of 93 per cent (15/16) and specificity of 92 per cent (1/13) which were confirmed by positive culture or clinical and laboratory follow-up. One AIDS patient had a false-negative result and one false-positive result (1/9) was obtained among the healthy subjects. All patients infected with varicella zoster virus were negative to the IVIAP test. The test is rapid, inexpensive, easy to interpret and can be used for the diagnosis of HSV infections, especially in immunocompromised patients.


Subject(s)
Humans , Herpes Simplex/diagnosis , In Vitro Techniques , Antibodies, Viral/analysis , Herpesvirus 1, Human/immunology , Herpesvirus 1, Human/isolation & purification , Immunocompromised Host/immunology
SELECTION OF CITATIONS
SEARCH DETAIL